Thromb Haemost 2005; 94(01): 224-225
Schattauer GmbH
The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease
Daniel P. Potaczek
1
Department of Medicine, Jagellonian University School of Medicine, Cracow, Poland
,
Anetta Undas
1
Department of Medicine, Jagellonian University School of Medicine, Cracow, Poland
,
Teresa Iwaniec
1
Department of Medicine, Jagellonian University School of Medicine, Cracow, Poland
,
Andrew Szczeklik
1
Department of Medicine, Jagellonian University School of Medicine, Cracow, Poland
› Author Affiliations
References
1
Cambien F,
Poitier O,
Lecerf L.
et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
2
Samani NJ,
Thompson JR,
O'Toole L.
et al. A metaanalysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-12.
3
Wells PS,
Rodger MA,
Forgie MA.
et al. The ACE D/D genotype is protective against the development of idiopathic deep wein thrombosis and pulmonaty embolism. Thromb Haemost 2003; 90: 829-34.
4
Fatini C,
Gensini F,
Sticchi E.
et al. ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur J Clin Invest 2003; 33: 642-7.
5
Jacoby DS,
Rader DJ.
Renin-angiotensin system and atherothrombotic disease. Arch Intern Med 2003; 163: 1155-64.
6
Undas A,
Celinska-Löwenhoff M,
Kaczor M.
et al. New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb Haemost 2004; 91: 1065-77.
7
Basso F,
Lowe GDO,
McMahon AD.
et al. Interleukin- 6 – 174G>C polymorphism and risk of coronary heart disease in West of Scotland Coronary Prevention Study (WOSCOPS). Atherioscler Thromb Vasc Biol 2002; 22: 599-604.
8
Marian AJ,
Safavi F,
Ferlic L.
et al. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin. J Am Coll Cardiol 2000; 35: 89-95.
9
Rigat B,
Hubert C,
Corvol P.
et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP-1) (dipeptydyl carboxipeptidase 1). Nucl Acids Res 1992; 20: 1433.
10
Makris TK,
Stavroulakis GA,
Dafni UG.
et al. ACE/ DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension. Am Heart J 2000; 140: 760-5.
11
Folsom AR.
Haemostatic risk factors for atherothrombotic disease: an epidemiologic view. Thromb Haemost 2001; 86: 366-73.
12
Blake GJ,
Ridker PM.
Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002; 252: 283-94.
